Patient Selection
This paper provides the insight on the biomarker discovery process and classifier development to reach a statistical performance necessary to serve the intended use of ThyroidPrint® (Rule-out).
Learn more
.svg)
ThyroidPrint ha sido validado en Estados Unidos y Chile mediante un estudio multicéntrico, prospectivo y doble ciego, donde se reclutaron 4.100 pacientes, los que constituyeron una gran cohorte multiétnica, que permitió concluir que el test tiene una alta efectividad independiente de la etnia del paciente.
Para validar el Cartridge Idylla ThyroidPrint® assay, se realizó un ensayo clínico de las mismas características, pero considerando además muestras provenientes de España, Brasil, Estados Unidos y Chile.
This paper provides the insight on the biomarker discovery process and classifier development to reach a statistical performance necessary to serve the intended use of ThyroidPrint® (Rule-out).
This review addresses the statistical rational supporting the intended use of molecular testing for indeterminate thyroid nodules.
This publication is reports two-independent multicenter – prospective trials that validate the clinical performance of ThyroidPrint® in two- ethnically diverse cohorts
This publication is a summary and comment by an independent expert about the clinical validation studies of ThyroidPrint®.
This publication is a summary and comment by an independent expert about the biomarker discovery & development of ThyroidPrint®.
With the widespread use of sensitive imaging techniques, which include neck visualization, a conspicuous number of thyroid nodules emerge and demand attention...
El test molecular que evita cirugías innecesarias
#KeepYourThyroid
América, Chile
Europa, españa
© Copyright 2024, All Rights Reserved by GeneproDX